Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapinarof cream in pediatric subjects with extensive atopic dermatitis
NCT05186805Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tapinarof in atopic dermatitis (AD), sponsored by Organon & Co.. Started Nov 2021; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05186805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05186805.